Tubeimoside I induces mitophagy by activating the PINK1/Parkin/Mfn2 signaling pathway in acute myeloid leukemia cells
Open Access
- 19 March 2025
- journal article
- Published by Elsevier in Translational Oncology
- Vol. 55, 102355
Abstract
No abstract availableKeywords
Funding Information
- Shanxi Provincial Department of Science and Technology (202203021212374, 202103021224299)
- Shanxi Medical University (XD2117, SD2210)
This publication has 44 references indexed in Scilit:
- Antitumor effect of tubeimoside-I on murine colorectal cancers through PKM2-dependent pyroptosis and immunomodulationNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Cancer cells reprogram to metastatic state through the acquisition of platelet mitochondriaCell Reports, 2023
- Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancerBiochemical Pharmacology, 2021
- Vitamin D promotes autophagy in AML cells by inhibiting miR-17-5p-induced Beclin-1 overexpressionMolecular and Cellular Biochemistry, 2021
- Tubeimoside I suppresses diabetes-induced bone loss in rats, osteoclast formation, and RANKL-induced nuclear factor-κB pathwayInternational Immunopharmacology, 2020
- Typhaneoside prevents acute myeloid leukemia (AML) through suppressing proliferation and inducing ferroptosis associated with autophagyBiochemical and Biophysical Research Communications, 2019
- DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritinFree Radical Biology and Medicine, 2019
- Molecular biomarkers in acute myeloid leukemiaBlood Reviews, 2017
- Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer TherapyJournal of Cellular Physiology, 2016
- PINK1/Parkin-mediated mitophagy in mammalian cellsCurrent Opinion in Cell Biology, 2015